What is the Gujarat Kidney And Super Speciality Ltd share price today?

The share price of NSE:GKSL-EQ on 01 Oct 2026 (as of 15:03:35 IST) is ₹194.56.

What is the NSE:GKSL-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:GKSL-EQ 52 week high low range shows a high of ₹209.8 and a low of ₹98.36.

What is the Gujarat Kidney And Super Speciality Ltd market cap?

As on 01 Oct 2026, Gujarat Kidney And Super Speciality Ltd market cap is ₹14156300000.

What is the shareholding pattern of Gujarat Kidney And Super Speciality Ltd Stock?

The shareholding pattern of Gujarat Kidney And Super Speciality Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 71.45% Foreign Institutional Investors (FII): 4.89% Domestic Institutional Investors (DII): 0.56% Mutual Funds: 0% Retail & Others: 23.1% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Gujarat Kidney And Super Speciality Ltd?

The Price-to-Earnings (PE) ratio of Gujarat Kidney And Super Speciality Ltd is 89.3988, and the Price-to-Book (PB) ratio is 3.1614, as on 01 Oct 2026.

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+4.76%

1 Week

+5.76%

1 Month

+13.79%

3 Month

+51.18%

6 Month

+73.40%

YTD

+89.07%

1 Year

NA

5 Year

NA

10 Year

NA

Max

+62.24%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

185.12

181.21

163.94

126.36

109.00

98.36

High

196.18

209.80

About

Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MANIPALHOSNSE

MAXHEALTHNSE

ASTERDMNSE

FORTISNSE

NHNSE

MEDANTANSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

GKSLNSE

LTP

1W Low

1W High

Market cap (₹)

7824-203.5 (-2.54%)

7688

8100

1,13,202Cr

650.05-51.25 (-7.31%)

647

707.05

87,861Cr

852.5-31.3 (-3.54%)

842.05

894.80

84,036Cr

675.2-24.65 (-3.52%)

673.30

706.30

60,058Cr

750-36.25 (-4.61%)

737.95

785.55

57,075Cr

1689.4-30.1 (-1.75%)

1663.50

1731.80

34,466Cr

1280-32.7 (-2.49%)

1257.50

1322.10

34,447Cr

1938+4.4 (0.23%)

1887.10

2002.50

32,084Cr

692.95-12.55 (-1.78%)

685.15

718.20

29,768Cr

467-10.75 (-2.25%)

463.45

480.95

14,956Cr

194.69+10.6 (5.76%)

181.21

196.18

1,465Cr

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year104%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year77%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-

Return on Equity

10 years54%

5 years54%

3 years81%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	104%
-	-	-	77%
-	-	-	-
54%	54%	81%	12%

Peer Comparison

Symbol

APOLLOHOSP

MANIPALHOS

MAXHEALTH

ASTERDM

FORTIS

NH

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

GKSL

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
7,809	₹113202 Cr	54.18	40.39	207.67	₹1942 Cr
657.85	₹87861 Cr	98.46	1.96	11.95	₹892 Cr
858.3	₹84036 Cr	57.68	3.31	19.84	₹1442 Cr
676.1	₹60058 Cr	188.46	0.31	6.76	₹388 Cr
744.7	₹57075 Cr	54.47	3.53	20.1	₹1042 Cr
1,693.4	₹34466 Cr	42.23	10.14	65.36	₹806 Cr
1,276.8	₹34447 Cr	61.94	5.91	29.85	₹556 Cr
1,937.5	₹32084 Cr	59.21	10.11	42.51	₹505 Cr
694.85	₹29768 Cr	145.71	1.04	12.74	₹241 Cr
468.5	₹14956 Cr	100.8	1.43	13.88	₹133 Cr
195.18	₹1465 Cr	92.54	0.66	2.66	₹15 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
₹34 Cr	₹31 Cr	₹23 Cr	₹13 Cr	₹15 Cr	₹10 Cr	₹12 Cr	₹9 Cr
₹69 L	₹71 L	₹6 L	₹9 L	₹80,000	₹5 L	₹5 L	₹5 L
₹35 Cr	₹31 Cr	₹23 Cr	₹13 Cr	₹15 Cr	₹10 Cr	₹12 Cr	₹9 Cr
₹27 Cr	₹26 Cr	₹18 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹5 Cr
₹9 Cr	₹7 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹3 Cr	₹5 Cr	₹5 Cr
₹66 L	₹82 L	₹60 L	₹28 L	₹18 L	₹16 L	₹17 L	₹16 L
₹7 Cr	₹5 Cr	₹5 Cr	₹4 Cr	₹7 Cr	₹2 Cr	₹4 Cr	₹4 Cr
₹5 Cr	₹5 Cr	₹4 Cr	₹3 Cr	₹5 Cr	₹1 Cr	₹3 Cr	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹16 Cr	₹11 Cr	₹20 L	₹20 L	₹20 L
₹0	₹0	₹9 Cr	₹0	₹0
₹237 Cr	₹15 Cr	₹2 Cr	₹17 L	₹18 L
₹237 Cr	₹15 Cr	₹2 Cr	₹17 L	₹18 L
₹253 Cr	₹26 Cr	₹11 Cr	₹37 L	₹38 L
₹2 Cr	₹1 Cr	₹0	₹0	₹0
₹77 L	₹2 Cr	₹2 Cr	₹0	₹0
₹1 Cr	₹50 L	₹0	₹0	₹0
-₹3 Cr	-₹68 L	-₹3 L	-₹4 L	-₹4 L
₹13 Cr	₹4 Cr	₹4 Cr	₹0	₹0
₹77 L	₹45 L	₹26 L	₹0	₹0
₹13 Cr	₹6 Cr	₹5 Cr	-₹4 L	-₹4 L
—	—	—	—	—
₹8 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr
₹6 Cr	₹16 Cr	₹2 Cr	₹3 L	₹3 L
₹13 Cr	₹1 Cr	₹0	₹0	₹0
₹19 L	₹2 Cr	₹39 L	₹0	₹48,000
₹28 Cr	₹22 Cr	₹4 Cr	₹3 Cr	₹4 Cr
₹295 Cr	₹55 Cr	₹20 Cr	₹4 Cr	₹4 Cr
₹0	₹3 L	₹0	₹0	₹0
₹16 Cr	₹4 Cr	₹2 Cr	₹0	₹0
—	—	—	—	—
₹152 Cr	₹37 Cr	₹14 Cr	₹0	₹3 Cr
₹23 Cr	₹6 Cr	₹32 L	₹0	₹57 L
₹129 Cr	₹31 Cr	₹14 Cr	₹0	₹3 Cr
₹12 Cr	₹0	₹0	₹0	₹0
₹12 Cr	₹0	₹0	₹0	₹0
₹48 Cr	₹13 L	₹6 L	₹0	₹0
₹2 Cr	₹2 Cr	₹7 L	₹3 Cr	₹0
₹191 Cr	₹33 Cr	₹14 Cr	₹3 Cr	₹3 Cr
—	—	—	—	—
₹2 Cr	₹68 L	₹27 L	₹0	₹0
₹39 Cr	₹15 Cr	₹4 Cr	₹1 Cr	₹1 Cr
₹56 Cr	₹3 Cr	₹1 Cr	₹35,000	₹34,000
₹77 L	₹87 L	₹90 L	₹0	₹0
₹7 Cr	₹2 Cr	₹18 L	₹0	₹0
₹105 Cr	₹22 Cr	₹7 Cr	₹1 Cr	₹1 Cr
₹77 Cr	₹15 L	₹2 Cr	-₹2 Cr	-₹2 Cr
₹295 Cr	₹55 Cr	₹20 Cr	₹4 Cr	₹4 Cr
₹32	₹5	₹87	₹19	₹19
₹32	₹5	₹0	₹0	₹0

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
₹21 Cr	₹13 Cr	₹2 Cr	-₹62,000	₹14 L
₹6 Cr	₹4 Cr	-₹23 L	₹0	₹57 L
-₹22 Cr	-₹35 L	-₹65 L	₹1 L	-₹61 L
₹6 Cr	₹16 Cr	₹1 Cr	₹50,000	₹10 L
-₹4 Cr	₹14 Cr	₹1 Cr	₹1,000	₹22,000
-₹214 Cr	-₹18 Cr	₹22 L	₹0	₹0
₹228 Cr	₹6 Cr	-₹47 L	₹0	₹0
₹11 Cr	₹2 Cr	₹97 L	₹1,000	₹22,000
₹3 Cr	₹97 L	₹35,000	₹34,000	₹12,000
₹13 Cr	₹3 Cr	₹97 L	₹35,000	₹34,000

Fundamental Ratios

Consolidated

Standalone

No results found

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 5

Bearish signals: 2 out of 9 oscillators

RSI

64.38Buy

STOCH %K

62.10Neutral

MACD Level(12,26)

6.37Buy

Ultimate Oscillator

43.86Sell

Aroon Oscillator

84.00Buy

BOP

0.72Buy

CCI

112.61Sell

Williams %R

-37.90Neutral

Momentum

16.98Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 7

Bearish signals: 0 out of 9 moving averages

EMA 9

186.28Buy

SMA 9

188.14Buy

EMA 21

181.09Buy

SMA 21

181.57Buy

EMA 50

168.12Buy

SMA 50

165.37Buy

EMA 200

0.00Neutral

SMA 200

0.00Neutral

WMA 20

184.40Buy

Pivot

Classic

Resistance 5

206.33

Resistance 4

200.89

Resistance 3

195.45

Resistance 2

190.01

Resistance 1

187.93

Pivot

184.57

Support 1

182.49

Support 2

179.13

Support 3

173.69

Support 4

168.25

Support 5

162.81

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

185.12

181.21

163.94

126.36

109.00

98.36

High

196.18

209.80

Returns

+8.84

+10.60

+23.60

+65.91

+82.41

+91.72

—

+74.69

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Shareholding summary

Promoters

71.45%

FII

6.52%

DII

0.25%

MF

0%

Others

21.78%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025
71.45%	71.45%	71.45%	71.45%	71.45%
6.52%	4.89%	4.89%	10.47%	13.09%
0.25%	0.56%	0.56%	1.67%	2.85%
0.00%	0.00%	0.00%	0.00%	0.00%
21.78%	23.10%	23.10%	16.41%	12.61%

Bulk & block deals

Name

Natvarsinh T Chavda

Qe Securities Llp

Natvarsinh T Chavda

Qe Securities Llp

Junomoneta Finsol Private Limited

Microcurves Trading Private Limited

Nk Securities Research Private Limited

Qe Securities Llp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
07 Oct 2026	Purchase	8.90 Cr	₹188.97	4.71 L	Bulk	0.597576	NSE
07 Oct 2026	Sell	9.34 Cr	₹192.19	4.86 L	Bulk	0.616601	NSE
05 Oct 2026	Purchase	13.64 Cr	₹189.10	7.21 L	Bulk	0.914939	NSE
05 Oct 2026	Purchase	8.54 Cr	₹192.61	4.43 L	Bulk	0.562308	NSE
05 Oct 2026	Sell	13.86 Cr	₹192.11	7.21 L	Bulk	0.914939	NSE
05 Oct 2026	Sell	8.13 Cr	₹190.48	4.27 L	Bulk	0.54166	NSE
01 Oct 2026	Purchase	29.89 Cr	₹198.86	15.03 L	Bulk	1.906598	NSE
01 Oct 2026	Purchase	29.95 Cr	₹199.79	14.99 L	Bulk	1.901206	NSE
01 Oct 2026	Purchase	20.60 Cr	₹199.83	10.31 L	Bulk	1.307579	NSE
01 Oct 2026	Purchase	18.58 Cr	₹197.12	9.43 L	Bulk	1.195677	NSE

Insider trading & SAST

Client name

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type

Gujarat Kidney And Super Speciality Share Price

194.69+8.84 (+4.76%)

+86.23% past 1 Year

Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are

Corporate Actions

Date

Type

Details

No data available.

Company details

Registered office

Plot No. 1, City Sarve No. 1537 / A Jetalpur Road, Gokak Mill Compound Alkapuri Vadodara Gujarat PIN: 390020 Tel No: 0265 2984800 Fax No: NULL Email: [email protected] Internet: www.gujaratsuperspecialityhospital.com

Registrars

C 101, 247 ParkLBS RoadVikhroli WestMumbai - 400083022-28207203-05-49186178-79022-28207207 C 101, 247 Park LBS Road Vikhroli West PIN: Tel No: 91-022-28207203-05-49186178-79 Fax No: 91-022-28207207 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Vishakha Mahesh Phadke, Company Secretary & Compliance Officer

Pragnesh Yashwantsinh Bharpoda, Chairman & Managing Director

Bhartiben Pragnesh Bharpoda, Whole Time Director

Anitaben Yashvantsinh Bharpoda, Non Executive Director

Jagdishbhai Vinodchandra Thakkar, Non Executive Independent Director

Udayan Maheshkant Kachchhi, Non Executive Independent Director

Kairavi Naimesh Shah, Non Executive Independent Director

Paresh Dhoti, Non Executive Independent Director

Details

Equity

GKSL

29 Sept 2025

Gujarat Kidney And Super Speciality Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Gujarat Kidney And Super Speciality Share Price

Gujarat Kidney And Super Speciality Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Gujarat Kidney And Super Speciality Share Price

Gujarat Kidney And Super Speciality Share Price

Oscillators

Moving averages

Gujarat Kidney And Super Speciality Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Gujarat Kidney And Super Speciality Share Price

Corporate Actions

Company details

Gujarat Kidney And Super Speciality Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Gujarat Kidney And Super Speciality Share Price

News

Gujarat Kidney and Super Speciality inform about newspaper publication

Guj. Kidney & Super reports Profit after tax of 1.37 Crores, in the March 2026 quarter

Gujarat Kidney and Super Speciality rises on getting nod to incorporate wholly owned subsidiary

Gujarat Kidney Q3 FY26 Results: Revenue Growth Accelerates Amid Margin Compression

Guj. Kidney & Super reports Profit after tax of 2.33 Crores, in the December 2025 quarter

GKSL Board Approves 51% Stake Acquisitions in Patel Pharmacy and Patel Hospital for Rs 12.50 Crores

Gujarat Kidney And Super Speciality: Board Greenlights 49% Stake Purchase In Harmony Medicare

Gujarat Kidney and Super Speciality informs about outcome of board meeting

Gujarat Kidney and Super Speciality to acquire Parekhs Hospital

Gujarat Kidney and Super Speciality Shares List at 6% Premium on BSE at Rs 120.75 vs Issue Price Rs 114.

Guj. Kidney & Super reports Profit after tax of 2.30 Crores, in the September 2025 quarter

Gujarat Kidney And Super Speciality Ltd Share Price Today

Gujarat Kidney And Super Speciality Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator